Pinnacle Financial Partners Inc lessened its position in The Allstate Co. (NYSE:ALL – Free Report) by 1.2% during the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 14,935 shares of the insurance provider’s stock after selling 181 shares during the period. Pinnacle Financial Partners Inc’s holdings in Allstate were worth $2,832,000 as of its most recent filing with the SEC.
Other large investors have also made changes to their positions in the company. Northwest Investment Counselors LLC acquired a new position in Allstate in the third quarter valued at about $28,000. Catalyst Capital Advisors LLC acquired a new stake in Allstate during the 3rd quarter valued at $29,000. Versant Capital Management Inc raised its position in Allstate by 70.9% in the 2nd quarter. Versant Capital Management Inc now owns 188 shares of the insurance provider’s stock valued at $30,000 after purchasing an additional 78 shares during the last quarter. Family Firm Inc. acquired a new position in Allstate in the second quarter worth $38,000. Finally, MCF Advisors LLC grew its holdings in shares of Allstate by 33.9% during the second quarter. MCF Advisors LLC now owns 332 shares of the insurance provider’s stock worth $53,000 after purchasing an additional 84 shares during the last quarter. Institutional investors own 76.47% of the company’s stock.
Insider Buying and Selling
In other Allstate news, insider John E. Dugenske sold 36,367 shares of the business’s stock in a transaction that occurred on Friday, September 20th. The stock was sold at an average price of $191.38, for a total value of $6,959,916.46. Following the sale, the insider now owns 27,364 shares in the company, valued at approximately $5,236,922.32. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. In other Allstate news, insider John E. Dugenske sold 36,367 shares of Allstate stock in a transaction on Friday, September 20th. The shares were sold at an average price of $191.38, for a total value of $6,959,916.46. Following the sale, the insider now directly owns 27,364 shares in the company, valued at approximately $5,236,922.32. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Thomas J. Wilson sold 90,000 shares of the firm’s stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $179.34, for a total value of $16,140,600.00. Following the completion of the transaction, the chief executive officer now owns 88,552 shares of the company’s stock, valued at $15,880,915.68. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 192,530 shares of company stock worth $34,967,665. 1.80% of the stock is owned by corporate insiders.
Allstate Stock Performance
Allstate (NYSE:ALL – Get Free Report) last posted its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $3.91 EPS for the quarter, beating the consensus estimate of $2.20 by $1.71. Allstate had a net margin of 6.77% and a return on equity of 26.67%. The business had revenue of $16.63 billion for the quarter, compared to analysts’ expectations of $14.57 billion. During the same period in the previous year, the firm posted $0.81 EPS. The firm’s revenue was up 14.7% compared to the same quarter last year. On average, analysts forecast that The Allstate Co. will post 16.02 EPS for the current fiscal year.
Analyst Ratings Changes
A number of equities research analysts have commented on the stock. TD Cowen increased their price objective on shares of Allstate from $193.00 to $224.00 and gave the stock a “buy” rating in a report on Tuesday, September 3rd. Piper Sandler increased their price target on shares of Allstate from $188.00 to $196.00 and gave the company an “overweight” rating in a research note on Friday, August 16th. The Goldman Sachs Group upped their price objective on Allstate from $199.00 to $204.00 and gave the stock a “buy” rating in a report on Thursday, August 15th. Keefe, Bruyette & Woods lifted their target price on Allstate from $222.00 to $225.00 and gave the company an “outperform” rating in a research note on Wednesday, November 6th. Finally, Evercore ISI raised their price target on Allstate from $191.00 to $195.00 and gave the company an “in-line” rating in a report on Wednesday, October 9th. One analyst has rated the stock with a sell rating, two have issued a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $212.56.
Get Our Latest Stock Report on Allstate
Allstate Profile
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Featured Articles
- Five stocks we like better than Allstate
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Rocket Lab is the Right Stock for the Right Time
- Short Selling: How to Short a Stock
- SoundHound AI Will Advance By Triple Digits in 2025: Here’s Why
- How to Calculate Options Profits
- Celsius Holdings: Big Drop, Big Opportunity? Analysts Say Yes
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.